Baterna, Nathaniel O.

HRN: 25-06-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2026
CEFUROXIME 750MG (VIAL)
02/25/2026
03/03/2026
IV
230mg
Q8
URTI, AGE
Checking Initial Appropriateness 
02/27/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
02/27/2026
03/06/2026
ORAL
1ml
QID
T/C PCAP; Aphthous Upcer
Checking Initial Appropriateness 
02/27/2026
CEFTRIAXONE 1G (VIAL)
02/27/2026
03/06/2026
IV
680mg
OD
T/C PCAP C; Aphtgous Ulcer
Checking Initial Appropriateness 
03/03/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/03/2026
03/10/2026
IV
35mg
Q8hours
T/C Hospital-acquired Pneumonia
Checking Initial Appropriateness 
03/04/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/04/2026
03/11/2026
IV
350mg
Q6hours
T/c Hospital-acquired Pneumonia; T/c Sepsis
Checking Initial Appropriateness 
03/04/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/04/2026
03/11/2026
TOPICAL
As Needed
TID
Phlebitis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: